evidence answer

Is Chromium Satiety Randomized Trial safe?

Updated August 2026

Quick Answer

Chromium Satiety Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: Secondary outcomes include cardiovascular disease risk markers, metabolic risk, metabolic gene profile analysis, dietary data, physical activity, satiety level, quality of life and cost analysis.

Key Takeaways

  • 01Secondary outcomes include cardiovascular disease risk markers, metabolic risk, metabolic gene profile analysis, dietary data, physical activity, satiety level, quality of life and cost analysis. [Che Wan Mansor WAN (2025)]
  • 02Introduction Uncontrolled type 2 diabetes mellitus (T2DM) causes microvascular and macrovascular issues that hike healthcare costs and threaten global health. [Che Wan Mansor WAN (2025)]
  • 03Previous studies have suggested meal replacement (MR) therapy for T2DM, but there were inconsistencies in the results. [Che Wan Mansor WAN (2025)]
The current Migaku evidence database contains 1 reusable source document for Chromium Satiety Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - Secondary outcomes include cardiovascular disease risk markers, metabolic risk, metabolic gene profile analysis, dietary data, physical activity, satiety level, quality of life and cost analysis. [Che Wan Mansor WAN (2025); evidence level 2] - Introduction Uncontrolled type 2 diabetes mellitus (T2DM) causes microvascular and macrovascular issues that hike healthcare costs and threaten global health. [Che Wan Mansor WAN (2025); evidence level 2] - Previous studies have suggested meal replacement (MR) therapy for T2DM, but there were inconsistencies in the results. [Che Wan Mansor WAN (2025); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Learn next

Keep learning from this answer

GuideChromium Satiety Randomized Trial: What the Evidence SaysChromium Satiety Randomized Trial has 1 source documents in the current Migaku evidence database...GuideChromium Blood Glucose Randomized Trial: What the Evidence SaysChromium Blood Glucose Randomized Trial has 2 source documents in the current Migaku evidence da...GuideChicory Root Fiber Satiety Randomized Trial: What the Evidence SaysChicory Root Fiber Satiety Randomized Trial has 2 source documents in the current Migaku evidenc...GuideRiboflavin Fatigue Randomized Trial: What the Evidence SaysRiboflavin Fatigue Randomized Trial has 1 source documents in the current Migaku evidence databa...DataChromium Satiety Randomized Trial Evidence TableStructured evidence table for Chromium Satiety Randomized Trial, generated from 1 reusable sourc...DataChromium Blood Glucose Randomized Trial Evidence TableStructured evidence table for Chromium Blood Glucose Randomized Trial, generated from 2 reusable...DataChicory Root Fiber Satiety Randomized Trial Evidence TableStructured evidence table for Chicory Root Fiber Satiety Randomized Trial, generated from 2 reus...

Sources

  1. Evaluating diabetes-specific meal replacements for glycaemic control in overweight and obese patients with T2DM: a protocol for a randomised controlled trial.